Scancell (LON:SCLP) Trading Up 29.8% – Here’s Why

Scancell Holdings plc (LON:SCLP)’s stock price shot up 29.8% during mid-day trading on Monday . The stock traded as high as GBX 11.38 ($0.15) and last traded at GBX 11 ($0.15). 10,537,342 shares changed hands during mid-day trading, an increase of 1,073% from the average session volume of 897,982 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Stock Down 5.1 %

The company has a debt-to-equity ratio of -566.79, a current ratio of 3.42 and a quick ratio of 13.01. The stock has a market cap of £103.20 million, a price-to-earnings ratio of -15.28 and a beta of 0.35. The firm has a 50 day simple moving average of GBX 8.51 and a two-hundred day simple moving average of GBX 10.85.

Scancell (LON:SCLP) last issued its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) EPS for the quarter. As a group, sell-side analysts expect that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.